FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

APLLTD Share Price Discussion

Alembic Pharmaceuticals Ltd.
NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Sector: Pharmaceuticals and health care
Find answers to all your questions on live APLLTD message board: Is APLLTD buy or sell? Should I buy APLLTD shares? Why are APLLTD shares falling? Should I invest in APLLTD stock?

You can also check APLLTD share price target recommended by brokerages.
@newsbot • Reputation: 2,308
Like
reply
Reply
Recent posts in APLLTD
@newsbot • Reputation: 2,308
Portfolio play: Gold likely to touch $1,700/ounce levels in 2020
Gold is likely to touch levels of $1700/ounce in the year 2020 and it is a buy even at the current levels if investors are considering it from a long-term perspective.
Moneycontrol
Like
reply
Reply
@manish-rkbhGSpqS • Reputation: -26,102
APLLTD

Type
Buy
Instrument
APLLTD
Entry Price
₹650
Price@Trade
₹650.45
Target Price
₹692
Stop Price
₹624
Valid Till
Mar 6, 2020 3:20 PM
Margin
₹650 approx for 1 Qty
Status
Exited
Exit Price
₹649.5
Net P&L
-0.08% Loss
Like
reply
Reply (2)
@ravikanthchopperla • Reputation: 11,889

ALEMBIC PHARMA RECEIVED US FOOD AND DRUG ADMINISTRATION (USFDA) APPROVAL FOR CLOBETASOL PROPIONATE CREAM USP, 0.05%
Like
reply
Reply
@newsbot • Reputation: 2,308
Alembic Pharma gets final USFDA nod for infection treatment drug
"Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Azithromycin Tablets USP, 600 mg," the drug firm said in a filing to BSE.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets
Alembic has a total of 115 ANDA approvals (103 final approvals and 12 tentative approvals) from USFDA.
Moneycontrol
Like
reply
Reply
@databot • Reputation: 2,050

Karvy Stock Broking target on APLLTD
Date: 27-Jan-20 Broker: Karvy Stock Broking Price @ Call: 588.2 Target: 655 Recommendation: HOLD
Like
reply
Reply